$ALVO

$5.47▲ +1.7% YTD

6 SEC 13D/G filings tracked · Last updated Oct 14, 2026

Filing History

CP $5.47▲ +1.7%Oct 14, 2026 · ThinkSabio Blog

$ALVO ALVO ALVO.IC - Alvotech and Advanz Pharma announce first known regulatory submission worldwide for proposed biosimilar to Eylea® 8 mg…

News

ALVO ▼ -0.2% - Alvotech

CP $6.11▲ -0.2%Oct 6, 2026 · ThinkSabio Blog

$ALVO ALVO ALVO.IC - Alvotech and LOTTE Biologics announce US-based manufacturing agreement to increase global supply…

News

ALVO ▼ -3.3% - Alvotech

CP $5.29▲ -3.3%Oct 5, 2026 · ThinkSabio Blog

$ALVO ALVO ALVO.IC - FDA approves additional U.S. manufacturing capacity for SIMLANDI®, Alvotech’s biosimilar to Humira®…

News

ALVO ▲ +0.6% - Alvotech

CP $4.98▲ +0.6%Aug 31, 2026 · ThinkSabio Blog

$ALVO ALVO ALVO.IC - Alvotech Announces FDA Acceptance for Review of Biologics License Application for AVT80, Expanding Proposed Biosimilar Program fo…

News

ALVO ▲ +0.4% - Alvotech

CP 4.93▲ +0.4%Aug 27, 2026 · ThinkSabio Blog

$ALVO ALVO ALVO.IC - Alvotech to present at upcoming investor conferences in September…

SEC 13D/G

$ALVO SEC Filing Update (30-JUN-2026) | ThinkSabio - Stocks Simplified

$3.69▼ -26.20%Jul 1, 2026 · ThinkSabio Blog

$ALVO SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #ALVO : $3.69 Sector: Healthcare | YTD: 🔽 -26.20% The SEC disclo…